Free Float 97,18 %
Shares Float 127,2 M
Shares Outstanding 130,89 M
Wuhan Hiteck Biological Pharma Co.,Ltd
Share · CNE1000034C5 (XSHE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Wuhan Hiteck Biological Pharma Co.,Ltd
No Price
Closing Price XSHE 29.04.2026:
35,25 CNY
29.04.2026 07:04
Current Prices from Wuhan Hiteck Biological Pharma Co.,Ltd
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 SHENZHEN STOCK EXCHANGE |
300683.SZ
|
CNY
|
29.04.2026 07:04
|
35,25 CNY
| -0,05 CNY
-0,14 %
|
Share Float & Liquidity
Company Profile for Wuhan Hiteck Biological Pharma Co.,Ltd Share
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacterial vaginosis rapid detection kit; measles virus IgG antibody detection kit; and coronavirus N-protein detection kit. In addition, it offers Lopinavir and Ritonavir APIs; and intermediates. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.
Company Data
Name Wuhan Hiteck Biological Pharma Co.,Ltd
Company Wuhan Hiteck Biological Pharma Co.,Ltd
Website
https://www.hiteck.com.cn
Primary Exchange
SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
ISIN CNE1000034C5
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Wen Xian
Market Capitalization 5 Mrd.
Country China
Currency CNY
Employees 1,5 T
Address Hite Science and Technology Park, 430056 Wuhan
IPO Date 2017-08-08
Dividends from 'Wuhan Hiteck Biological Pharma Co.,Ltd'
| Ex-Date | Dividend per Share |
|---|---|
| 09.01.2025 | 0,13 CNY |
| 01.07.2020 | 0,16 CNY |
| 17.06.2019 | 0,20 CNY |
| 23.05.2018 | 0,30 CNY |
Ticker Symbols
| Name | Symbol |
|---|---|
| SHENZHEN STOCK EXCHANGE | 300683.SZ |
More Shares
Investors who hold Wuhan Hiteck Biological Pharma Co.,Ltd also have the following shares in their portfolio:
